Results of early phase anti- IL-17 reported from WMR


Dr. Martin, Head and Eggebeen and colleagues reported the results of an early phase clinical trial conducted at West Michigan Rheumatology as a part of their broader thread of investigations of innovative biologic therapy for rheumatoid arthritis.  

Click the link to access the article


©2015 West Michigan Rheumatology, PLLC                1155 East Paris SE, Suite 100                              Grand Rapids, MI 49546                                               Voice 616.459.8088                                                       FAX 616.459.8312                                                www.mi-arthritis.com